SLAM: Life Sciences at Google: Leaning into the Newest Silicon Valley Bug

Seminar | October 30 | 5:30-6:30 p.m. | 106 Stanley Hall

 Dr. Jane Wang, Verily

 QB3 - California Institute for Quantitative Biosciences

Dr. Jane Wang earned her B.S. from the California Institute of Technology in 2007 before moving to pursue her Ph.D. in Chemistry, as a Hertz Fellow, at UC Berkeley in the lab of Prof. Dean Toste. In the Toste lab her research focused on developing new catalytic and enantioselective methods for the addition of nitrogen and oxygen nucleophiles to olefins. She continued her career as a post-doctoral fellow at the California Institute of Technology in the lab of Prof. Frances Arnold on directed evolution of cytochrome p450 for catalysis. In 2014 she began working at Google Life Sciences which has since split off to become part of the Google Alphabet as verily Life Sciences. Jane is currently the Tech Lead and Sr. Scientist of a lab at Verily focused on developing nanoparticle platforms for oncology applications including automated chemical synthesis of nanoparticle libraries, in vitro cell screening and pre-clinical development. Jane has been the recipient of the Dow Sustainability Innovation Challenge, Grand Prize, the National Institute of Health Ruth Kirschstein National Research Service Award, the Roche Excellence in Chemistry Prize, the John and Fannie Hertz Graduate Fellowship, and the Richard Schuster Memorial Prize for Chemistry.